Guided Therapeutics Provides Progress Update on

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
797
Guided Therapeutics Provides Progress Update on International Activities

10:19 am ET June 21, 2018 (BusinessWire)

Guided Therapeutics, Inc. (OTCQB: GTHP),
the maker of a rapid and painless testing platform based on its patented biophotonic technology, continues to make progress with commercial activities internationally.

1. China. We are in the process of transferring manufacturing to our commercialization partner in China for the Chinese market. In addition, we are working with the distributor on the clinical protocol for submission to the Chinese FDA. We hope to be approved for sale in China in the second half of 2019.

2. Indonesia. LuViva tests have increased as reflected by increased orders of single-use cervical guides, with the next order expected in July. Additional LuViva devices have been requested by the distributor prior to the end of this year.

3. India. We announced that we are approved for sale in India. Based upon mutual agreement of a Letter of Intent, we are planning a 2 week sales trip to the 6 major cities in September or October. We expect the initial order from India by the end of 2018.

4. Turkey. We announced a large contract in early April with $1.1 million in payments due in 2018. The contract is still on track but it has been delayed due to the recent financial and political issues in Turkey. We expect to get the payments in from this contract after the political elections have taken place.

5. Russia/Eastern Europe. Our distribution partner reported a successful presentation at a medical meeting in Minsk and is working with the Russian FDA towards approval.

6. Financing. Our goal is to reduce our liabilities and to obtain solid financing for the company to provide a two year runway for further commercial growth. We continue to pursue the financing.

7. FDA follow-up. We have not had the financial resources to do the confirmatory study that the FDA requires. We will restart that FDA work as soon as we complete our financing and we anticipate FDA approval 18 to 24 months later.

About LuViva(R) Advanced Cervical Scan

The LuViva is a technologically advanced diagnostic device that scans the cervix with light and uses spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of precancer that may be below the surface of the cervix or misdiagnosed as benign. This technique is called biophotonics. Unlike Pap, HPV tests or biopsies, LuViva does not require laboratory analysis or a tissue sample, and is designed to provide results immediately, which may result in eliminating costly, painful and unnecessary additional testing. LuViva is intended for use with women who have undergone initial screening and are called back for follow up with a colposcopy examination, which in many cases, involves taking a biopsy of the cervix. It has also been used in clinical studies in Turkey, Indonesia, and Nigeria as a means to screen women for cervical cancer where the availability of infrastructure necessary for Pap and HPV testing is restricted. The device is used in conjunction with the LuViva(R) Cervical Guide single-use patient interface.

About Guided Therapeutics

Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva(R) Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: www.guidedinc.com.

The Guided Therapeutics LuViva(R) Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc.

Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading "Risk Factors" in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and subsequent filings.

http://cts.businesswire.com/ct/CT?id=bwnews&a...mp;lang=en

View source version on businesswire.com: https://www.businesswire.com/news/home/20180621005772/en/

SOURCE: Guided Therapeutics, Inc.

Guided Therapeutics
Mark Faupel, 770-242-8723

Guided Therapeutics, Inc. (GTHP) Stock Research Links

GTHP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 187

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 169

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 302

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Community Engagement Takes Center Stage at SAS Championship

Updated Category News Views 196

Community Engagement Takes Center Stage at SAS Championship Community initiative supports local teachers, sparks student interest in technology Teachers often face financial challenges covering classroom needs, especially in STEM (science, technology, engineering, and math) education, which is critical for preparing students for a tech-driven future. To alleviate this,...

Continue Reading
Explore Yaber's Next-Gen Projectors Unveiled at CES 2025

Updated Category News Views 305

Innovative Projectors Unveiled by Yaber at CES 2025 Yaber, renowned for its cutting-edge entertainment projectors, revealed its latest models at the CES 2025 event. Among these, the K300s, L2 Plus, and T2 Series stand out, showcasing incredible advancements in home entertainment technology. These projectors are designed to elevate the viewing experience, whether you're...

Continue Reading
Important Update for UroGen Pharma Investors Ahead of Deadline

Updated Category News Views 188

UroGen Pharma Investors: Key Deadline Approaching Attention UroGen Pharma Ltd. investors! The clock is ticking on an important opportunity that you won't want to miss. The class action lawsuit involving UroGen Pharma (URGN) has reached a crucial stage and if you've been affected, now is the time to act. The deadline for an essential step in the lawsuit is coming up on...

Continue Reading
Enhancing Workplace Safety with Voxel's Innovative Impact Boards

Updated Category News Views 121

Revolutionizing Workplace Safety with AI Insights In today's fast-paced work environment, ensuring safety and operational efficiency is paramount. Voxel, an Applied AI company dedicated to transforming workplace safety, has launched its latest innovation: the Impact Boards. These boards are designed to provide tailored, shift-specific safety insights that enable teams to...

Continue Reading
First Quantum Minerals Expands Senior Notes Offering Leadership

Updated Category News Views 112

First Quantum Minerals Expands Senior Notes Offering In a significant development, First Quantum Minerals Ltd. (TSX: FM) has announced a remarkable $1 billion offering of senior notes, demonstrating its strong standing in the mining industry. The company has increased the original offering amount from $750 million to $1 billion, clearly indicating investor confidence and...

Continue Reading